AbCellera Biologics Inc.

ABCL • NASDAQ • Stock Fundamentals

AbCellera Biologics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carl Hansen, with a market cap of $1.6B.

Market Cap$1.6B

Employees586.0

CEOCarl Hansen

CountryCanada

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about AbCellera Biologics Inc.

AbCellera Biologics Inc. (ABCL) has a market capitalization of $1.6B and trades on NASDAQ.

AbCellera Biologics Inc. has approximately 586 employees.